Literature DB >> 22985337

Mouse primed embryonic stem cells could be maintained and reprogrammed on human amnion epithelial cells.

Yi-Fei Chen1, Zhangli Dong, Lizheng Jiang, Dongmei Lai, Lihe Guo.   

Abstract

Naïve and primed embryonic stem cells (ESCs) represent 2 pluripotent states of mouse embryonic stem cells (mESCs), corresponding to the pre- and postimplantation cells, respectively, in vivo. Primed ESCs are distinct from naïve cells in biological characteristics, genetic features, developing potentials, and antagonistic signal pathway dependences to support undifferentiated growth. In vitro, naïve mESCs are readily converted to primed cells upon transferring to primed pluripotency signaling. ESC-derived epiblast stem cells (ESD-EpiSCs) are stabilized primed cells derived from naïve mESCs in vitro, and cannot be maintained with leukemia inhibitory factor (LIF) signaling with or without mouse embryonic fibroblasts as the feeder layer. Here, we show that the undifferentiated growth of ESD-EpiSCs could be maintained with the basic fibroblast growth factor employing human amnion epithelial cells (hAECs) as the feeder layer. Upon exposure to LIF, ESD-EpiSCs could undergo a reprogramming process on hAECs and be converted to naïve-like cells converted ESCs (cESCs), in which naïve pluripotency markers were activated, and primed markers were suppressed. DNA methylation analysis also validated the epigenetic conversion from primed to naïve-like pluripotent status. The bone morphogenetic protein 4 (BMP4) is an important signaling factor in pluripotency controlling, germ cell development, and neural commitment. It showed that ESD-EpiSCs and cESCs exhibited different features toward BMP4. Our results prove that hAECs are ideal feeder cells for both naïve and primed ESCs. More importantly, the primed ESCs are allowed to be reprogrammed to naïve-like pluripotent cells on hAECs. These findings suggest that under suitable conditions primed ESCs have the potency of converting to naïve-like ESCs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22985337     DOI: 10.1089/scd.2012.0325

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  5 in total

1.  Osteogenic differentiation of human amniotic epithelial cells and its application in alveolar defect restoration.

Authors:  Si Jiawen; Zhang Jianjun; Dai Jiewen; Yu Dedong; Yu Hongbo; Shi Jun; Wang Xudong; Steve G F Shen; Guo Lihe
Journal:  Stem Cells Transl Med       Date:  2014-11-03       Impact factor: 6.940

Review 2.  Pluripotent states of human embryonic stem cells.

Authors:  Yifei Chen; Dongmei Lai
Journal:  Cell Reprogram       Date:  2014-11-13       Impact factor: 1.987

3.  Mouse embryonic fibroblast (MEF)/BMP4-conditioned medium enhanced multipotency of human dental pulp cells.

Authors:  Lu Liu; Zhengjun Peng; Zhezhen Xu; Haoquan Huang; Xi Wei
Journal:  J Mol Histol       Date:  2017-12-06       Impact factor: 2.611

4.  Nucleoside analog inhibits microRNA-214 through targeting heat-shock factor 1 in human epithelial ovarian cancer.

Authors:  Yi-Fei Chen; Zhangli Dong; Yi Xia; Jingjie Tang; Ling Peng; Shuying Wang; Dongmei Lai
Journal:  Cancer Sci       Date:  2013-10-22       Impact factor: 6.716

5.  Derivation and characterization of human embryonic stem cells on human amnion epithelial cells.

Authors:  Dongmei Lai; Yongwei Wang; Jian Sun; Yifei Chen; Ting Li; Yi Wu; Lihe Guo; Chunsheng Wei
Journal:  Sci Rep       Date:  2015-05-07       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.